Physiomics Plc (AIM:PYC)
0.5000
0.00 (0.00%)
Jul 24, 2026, 4:28 PM GMT
Physiomics Revenue
Physiomics had revenue of 528.00K GBP in the half year ending December 31, 2025, with 38.22% growth. This brings the company's revenue in the last twelve months to 1.01M, up 85.79% year-over-year. In the fiscal year ending June 30, 2025, Physiomics had annual revenue of 834.00K with 46.17% growth.
Revenue (ttm)
1.01M
Revenue Growth
+85.79%
P/S Ratio
2.14
Revenue / Employee
100.82K
Employees
10
Market Cap
2.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 834.00K | 263.44K | 46.17% |
| Jun 30, 2024 | 570.56K | -35.17K | -5.81% |
| Jun 30, 2023 | 605.73K | -294.97K | -32.75% |
| Jun 30, 2022 | 900.71K | 169.81K | 23.23% |
| Jun 30, 2021 | 730.90K | -111.10K | -13.19% |
| Jun 30, 2020 | 842.00K | 58.90K | 7.52% |
| Jun 30, 2019 | 783.10K | 270.20K | 52.68% |
| Jun 30, 2018 | 512.90K | 242.43K | 89.64% |
| Jun 30, 2017 | 270.47K | -26.66K | -8.97% |
| Jun 30, 2016 | 297.12K | 61.63K | 26.17% |
| Jun 30, 2015 | 235.49K | -32.51K | -12.13% |
| Jun 30, 2014 | 268.00K | 28.00K | 11.67% |
| Jun 30, 2013 | 240.00K | 104.69K | 77.38% |
| Jun 30, 2012 | 135.31K | 81.96K | 153.64% |
| Jun 30, 2011 | 53.35K | -99.35K | -65.06% |
| Jun 30, 2010 | 152.69K | -306.86K | -66.77% |
| Jun 30, 2009 | 459.55K | 368.33K | 403.78% |
| Jun 30, 2008 | 91.22K | -125.24K | -57.86% |
| Jun 30, 2007 | 216.46K | 103.35K | 91.37% |
| Jun 30, 2006 | 113.11K | -91.59K | -44.74% |
| Jun 30, 2005 | 204.70K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 1.70M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |
| BSF Enterprise | 51.07K |
| ValiRx | 31.37K |
| Thalia Therapeutics | 7.26K |
Physiomics News
- 13 days ago - AIM Market Roundup: Mothercare, Buccaneer Energy, Physiomics - The Armchair Trader
- 3 months ago - ISS weighs in on Physiomics ahead of general meeting - The Armchair Trader
- 3 months ago - Physiomics board pushes back against shareholder challenge - The Armchair Trader
- 4 months ago - AIM Market Roundup: Physiomics, Tern, Cleantech Lithium - The Armchair Trader
- 6 months ago - AIM Market Roundup: Physiomics, Harvest Minerals, Blue Star Capital - The Armchair Trader
- 8 months ago - AIM Market Roundup: Genincode, Proteome Sciences, Caspian Sunrise - The Armchair Trader
- 10 months ago - Full Year 2025 Physiomics PLC Investor Presentation Transcript - GuruFocus
- 1 year ago - AIM Market Roundup: Future Metals, Eurasia Mining, Blackbird - The Armchair Trader